<DOC>
	<DOCNO>NCT01996475</DOCNO>
	<brief_summary>Objective : Primary objective present study compare single dose bioavailability Torrent 's Escitalopram Oxalate Tablet 20 mg [ Test formulation , Torrent Pharmaceuticals Ltd. , India ] Versus Lexapro® ( Escitalopram Oxalate Tablet 20 mg ) [ Reference formulation , Forest Laboratories Inc , USA ] . Dosing period separate washout period feed study . Study Design : Open-Label , Randomised , two Period , two treatment , Crossover , Single-Dose Bioequivalence Study</brief_summary>
	<brief_title>Bioequivalence Study Torrent Pharmaceutical Ltd. 's Escitalopram Oxalate Tablets Under Fed Condition</brief_title>
	<detailed_description />
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<criteria>The volunteer include study base follow criterion : Sex : male . Age : 18 45 year . Volunteer BMI 1827 ( inclusive ) kg/m2 minimum 50 kg weight . Healthy willing participate study . Volunteer willing adhere protocol requirement provide write informed consent . Nonsmokers smoker smoke less 10 cigarette per day The volunteer exclude study base follow criterion : Clinically relevant abnormality result laboratory screening evaluation . Clinically significant abnormal ECG Chest Xray . Systolic blood pressure le 100 mm Hg 140 mm Hg diastolic blood pressure le 60 mm Hg 90 mm Hg . Pulse rate less 50/minute 100/minute . Oral temperature le 95°P 98.6°P . Respiratory rate le 12/minute 20/minute History allergy test drug drug chemically similar drug investigation . History alcohol drug abuse Positive breath alcohol test Recent history kidney liver dysfunction . History consumption prescribe medication since last 14 day OTC medication since last 07 day begin study . Volunteers suffer chronic illness arthritis , asthma etc . History heart failure . HIV , HCV , HBsAg positive volunteer . Opiate , tetra hydrocannabinol , amphetamine , barbiturate , benzodiazepine , Cocaine positive volunteer base urine test . Volunteers suffer psychiatric ( acute chronic ) illness require medication . Administration study drug period 0 3 month entry study . History significant blood loss due reason , include blood donation past 3 month . History preexist bleed disorder . Existence surgical medical condition , , judgment chief investigator and/or clinical investigator/physician , might interfere absorption , distribution , metabolism excretion drug likely compromise safety volunteer . Inability communicate cooperate due language problem , poor mental development impair cerebral function .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>